2026 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium

LIVE
2026 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium Banner

Add to Calendar 2026 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium 5/6/2026 7:30:00 AM 5/7/2026 5:30:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/2026MDS Description: Myelodysplastic Syndromes (MDS) remain a major challenge in hematologic oncology, with effective treatment hinging on deeper insights into stem cell biology under both normal and stress conditions. The upcoming MDS symposium will bring together international experts in hematopoiesis and MDS to exchange knowledge, spark new ideas, and accelerate progress in molecular research and therapeutic innovation. By fostering colla... MD Anderson - Onstead Auditorium false MM/DD/YYYY


Date & Location
Wednesday, May 6, 2026, 7:30 AM - Thursday, May 7, 2026, 5:30 PM, MD Anderson - Onstead Auditorium, Houston, TX

Target Audience
Specialties - Hematology, Hematopathology, Pathology
Professions - Other, Physician (MD or DO), Student or Trainee

Credits
AMA PRA Category 1 Credits™ (13.00 hours), Non-Physician Attendance (13.00 hours)

Overview
Myelodysplastic Syndromes (MDS) remain a major challenge in hematologic oncology, with effective treatment hinging on deeper insights into stem cell biology under both normal and stress conditions. The upcoming MDS symposium will bring together international experts in hematopoiesis and MDS to exchange knowledge, spark new ideas, and accelerate progress in molecular research and therapeutic innovation. By fostering collaboration across disciplines, this event aims to advance our understanding of MDS and improve care for patients affected by this complex disease.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Examine the cellular and molecular processes that regulate hematopoietic stem cell function under normal and stress-induced conditions, and their role in the development of Myelodysplastic Syndromes (MDS).
  2. Assess both established and novel therapeutic approaches for MDS in light of recent advances in hematopoietic stem cell biology.
  3. Utilize current insights into MDS pathobiology to interpret diagnostic data and evaluate prognostic indicators, including molecular profiles, to enhance clinical decision-making and patient care.
  4. Apply emerging insights from international experts in stem cell biology and myelodysplastic syndromes (MDS) to enhance interdisciplinary collaboration, inform strategic clinical research initiatives, and drive innovation in therapeutic approaches aimed at improving patient outcomes in hematologic oncology.

Registration

On-site registration for the 2026 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium, will open at 7:00 AM on Wednesday, May 6, 2026 at the Onstead Auditorium located in the Mitchell Building (BSRB) Floor 3, 6767 Bertner Avenue.

The symposium will begin with opening remarks at 8:20 AM and will adjourn for the day at 5:00 PM. The symposium will reconvene on Thursday, May 7, 2026 at 8:30 AM and adjourn at 5:30 PM. Advanced registration is encouraged as space and materials are limited. 

The deadline for advanced registration is Sunday, May 3, 2026


We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to: 

Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
 P.O. Box 301407
 Houston, Texas 77230-1407

Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy The registration fee, minus a $15.00 administration-handling fee, is refundable if a written request is received on or before Monday, April 13, 2026.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance For additional information or if you have any ADA accommodation needs, Contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 13 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

View the accessibility policy for The University of Texas MD Anderson Cancer Center.